US 11,725,010 B2
Polyheterocyclic compounds as METTL3 inhibitors
Wesley Peter Blackaby, Cambridge (GB); Elizabeth Jane Thomas, Cambridge (GB); David James Hardick, Cambridge (GB); Jon Shepherd, Oxfordshire (GB); Frederick Arthur Brookfield, Oxfordshire (GB); Christian Bubert, Oxfordshire (GB); and Mark Peter Ridgill, Oxfordshire (GB)
Assigned to Storm Therapeutics Limited, Cambridge (GB)
Filed by Storm Therapeutics Limited, Cambridge (GB)
Filed on Jul. 29, 2022, as Appl. No. 17/876,938.
Application 17/876,938 is a continuation of application No. 17/778,701, previously published as PCT/GB2020/053081, filed on Dec. 1, 2020.
Claims priority of application No. 1917603 (GB), filed on Dec. 2, 2019; application No. 2015692 (GB), filed on Oct. 2, 2020; and application No. 2015820 (GB), filed on Oct. 6, 2020.
Prior Publication US 2023/0002378 A1, Jan. 5, 2023
Int. Cl. C07D 471/04 (2006.01)
CPC C07D 471/04 (2013.01) 3 Claims
 
1. A compound having the structure:

OG Complex Work Unit Chemistry
or a pharmaceutically acceptable salt thereof.